The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Drugs targeting the renin–angiotensin–aldosterone system
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Self-citationThe effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
Swedberg, K., & Kjekshus, J. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
The world health report 2001 - Mental health: new understanding, new hope
Sayers, J. G. (2001) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862001001100014 · Cited by 3,123
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
Hansson, L., Lindholm, L. H., Niskanen, L., Lanke, J., Hedner, T., Niklason, A., Luomanmäki, K., Dahlöf, B., de Faire, U., Mörlin, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05012-0 · Cited by 2,014
Pitt, B., Poole-Wilson, P. A., Segal, R., Martinez, F. A., Dickstein, K., Camm, A. J., Konstam, M. A., Riegger, G., Klinger, G. H., Neaton, J., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02213-3 · Cited by 1,961
Ondetti, M. A., Rubin, B., & Cushman, D. W. (1977) · Science · doi:10.1126/science.191908 · Cited by 1,856
Garg, R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520420066040 · Cited by 1,771
Pitt, B., Segal, R., Martinez, F. A., Meurers, G., Cowley, A. J., Thomas, I., Deedwania, P. C., Ney, D. E., Snavely, D. B., & Chang, P. I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01187-2 · Cited by 1,665
Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08090-x · Cited by 1,560
Self-citationHansson, L., Lindholm, L. H., Ekbom, T., Dahlöf, B., Lanke, J., Scherstén, B., Wester, P.-O., Hedner, T., & de Faire, U. (1999) · The Lancet · doi:10.1016/s0140-6736(99)10327-1 · Cited by 1,447
Preserving renal function in adults with hypertension and diabetes: A consensus approach
Bakris, G. L., Williams, M., Dworkin, L., Elliott, W. J., Epstein, M., Toto, R., Tuttle, K., Douglas, J., Hsueh, W., & Sowers, J. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.16225 · Cited by 1,411
Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial Infarction
Pfeffer, M. A., Lamas, G. A., Vaughan, D. E., Parisi, A. F., & Braunwald, E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807143190204 · Cited by 1,103
Essential Hypertension: Renin and Aldosterone, Heart Attack and Stroke
Brunner, H. R., Laragh, J. H., Baer, L., Newton, M. A., Goodwin, F. T., Krakoff, L. R., Bard, R. H., & Bühler, F. R. (1972) · New England Journal of Medicine · doi:10.1056/nejm197203022860901 · Cited by 1,093
Jafar, T. H., Schmid, C. H., Landa, M., Giatras, I., Toto, R., Remuzzi, G., Maschio, G., Brenner, B. M., Kamper, A., Zucchelli, P., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-2-200107170-00007 · Cited by 1,092
Reid, I. A., Morris, B. J., & Ganong, W. F. (1978) · Annual Review of Physiology · doi:10.1146/annurev.ph.40.030178.002113 · Cited by 953
Zannad, F., Alla, F., Dousset, B., Perez, A., & Pitt, B. (2000) · Circulation · doi:10.1161/01.cir.102.22.2700 · Cited by 947
Agodoa, L. Y. (2001) · JAMA · doi:10.1001/jama.285.21.2719 · Cited by 944
Mukoyama, M., Nakajima, M., Horiuchi, M., Sasamura, H., Pratt, R. E., & Dzau, V. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74498-6 · Cited by 768
Alderman, M. H., Madhavan, S., Ooi, W. L., Cohen, H., Sealey, J. E., & Laragh, J. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241605 · Cited by 730
Angiotensin II receptor antagonists
Burnier, M., & Brunner, H. (2000) · The Lancet · doi:10.1016/s0140-6736(99)10365-9 · Cited by 707
McKelvie, R. S., Yusuf, S., Pericak, D., Avezum, A., Burns, R. J., Probstfield, J., Tsuyuki, R. T., White, M., Rouleau, J., Latini, R., et al. (1999) · Circulation · doi:10.1161/01.cir.100.10.1056 · Cited by 692
Schmieder, R. E. (1996) · JAMA · doi:10.1001/jama.1996.03530430051039 · Cited by 604
Davis, B. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)00037-4 · Cited by 595
Angiotensin Receptors and Their Antagonists
Goodfriend, T. L., Elliott, M. E., & Catt, K. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606203342507 · Cited by 558
Franzosi, M. G., Santoro, E., Zuanetti, G., Baigent, C., Collins, R., Flather, M. D., Kjekshus, J., Latini, R., Liu, L., Maggioni, A. P., et al. (1998) · Circulation · Cited by 536
Vaughan, D. E., Lazos, S. A., & Tong, K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117809 · Cited by 530
Bebbington, P. (2001) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270170010 · Cited by 513
A BRADYKININ‐POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARACA
FERREIRA, S. H. (1965) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1965.tb02091.x · Cited by 509
Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
Brilla, C. G., & Weber, K. T. (1992) · PubMed · Cited by 505
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
Lonn, E. M., Yusuf, S., Jha, P., Montague, T. J., Teo, K. K., Benedict, C. R., & Pitt, B. (1994) · Circulation · doi:10.1161/01.cir.90.4.2056 · Cited by 503
Evidence That the Angiotensin IV (AT4) Receptor Is the Enzyme Insulin-regulated Aminopeptidase
Albiston, A. L., McDowall, S. G., Matsacos, D., Sim, P., Clune, E., Mustafa, T., Lee, J., Mendelsohn, F. A. O., Simpson, R. J., Connolly, L. M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100512200 · Cited by 461
Gainer, J. V., Morrow, J. D., Loveland, A., King, D. J., & Brown, N. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810293391804 · Cited by 443
Giatras, I., Lau, J., & Levey, A. S. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-5-199709010-00001 · Cited by 427
Ridker, P. M., Gaboury, C. L., Conlin, P. R., Seely, E. W., Williams, G. H., & Vaughan, D. E. (1993) · Circulation · doi:10.1161/01.cir.87.6.1969 · Cited by 400
Converting-Enzyme Inhibitors in the Treatment of Hypertension
Oates, J. A., Wood, A. J. J., & Williams, G. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812083192305 · Cited by 364
Linz, W., Schölkens, B. A., & Ganten, D. (1989) · Clinical and Experimental Hypertension. Part A: Theory and Practice · doi:10.3109/10641968909038172 · Cited by 336
Hornig, B., Kohler, C., & Drexler, H. (1997) · Circulation · doi:10.1161/01.cir.95.5.1115 · Cited by 333
THE PREPARATION, PURIFICATION, AND AMINO ACID SEQUENCE OF A POLYPEPTIDE RENIN SUBSTRATE
Skeggs, L. T., Kahn, J. R., Lentz, K., & Shumway, N. P. (1957) · The Journal of Experimental Medicine · doi:10.1084/jem.106.3.439 · Cited by 316
Ravid, M. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440030080010 · Cited by 314
Oparil, S., & Haber, E. (1974) · New England Journal of Medicine · doi:10.1056/nejm197408222910805 · Cited by 308
Self-citationKerins, D. M., Hao, Q., & Vaughan, D. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118312 · Cited by 304
Vasopeptidase Inhibitors: A New Therapeutic Concept in Cardiovascular Disease?
Corti, R., Burnett Jr, J. C., Rouleau, J. L., Ruschitzka, F., & Lüscher, T. F. (2001) · Circulation · doi:10.1161/hc4001.097191 · Cited by 300
Mosterd, A., D'Agostino, R. B., Silbershatz, H., Sytkowski, P. A., Kannel, W. B., Grobbee, D. E., & Levy, D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401601 · Cited by 283
Efficacy and tolerance of spironolactone in essential hypertension
Jeunemaitre, X., Chatellier, G., Kreft-Jais, C., Charru, A., Devries, C., Plouin, P.-F., Corvol, P., & Menard, J. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91030-7 · Cited by 276
Effect of Activation and Inhibition of the Renin-Angiotensin System on Plasma PAI-1
Brown, N. J., Agirbasli, M. A., Williams, G. H., Litchfield, W. R., & Vaughan, D. E. (1998) · Hypertension · doi:10.1161/01.hyp.32.6.965 · Cited by 269
Oparil, S., Williams, D., Chrysant, S. G., Marbury, T. C., & Neutel, J. (2001) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2001.01136.x · Cited by 265
Self-citationDZAU, V. J., ELLISON, K. E., BRODY, T., INGELFINGER, J., & PRATT, R. E. (1987) · Endocrinology · doi:10.1210/endo-120-6-2334 · Cited by 261
Functional and Biochemical Analysis of Angiotensin II–Forming Pathways in the Human Heart
Wolny, A., Clozel, J.-P., Rein, J., Mory, P., Vogt, P., Turino, M., Kiowski, W., & Fischli, W. (1997) · Circulation Research · doi:10.1161/01.res.80.2.219 · Cited by 244
Biollaz, J., Brunner, H. R., Gavras, I., Waeber, B., & Gavras, H. (1982) · PubMed · Cited by 238
Linz, W., & Schölkens, B. A. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09054.x · Cited by 236
Levy, B. I., Benessiano, J., Henrion, D., Caputo, L., Heymes, C., Duriez, M., Poitevin, P., & Samuel, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118807 · Cited by 233
Balcells, E., Meng, Q. C., Johnson, W. H., Oparil, S., & Dell’Italia, L. J. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.273.4.h1769 · Cited by 223
Self-citationProposed Update of Angiotensin Receptor Nomenclature
de Gasparo, M., Husain, A., Alexander, W., Catt, K. J., Chiu, A. T., Drew, M., Goodfriend, T., Harding, J. W., Inagami, T., & Timmermans, P. B. M. W. M. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.924 · Cited by 219
Dell'Italia, L. J., Meng, Q. C., Balcells, E., Wei, C. C., Palmer, R., Hageman, G. R., Durand, J., Hankes, G. H., & Oparil, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119529 · Cited by 216
Self-citationAngiotensin II-Forming Activity in a Reconstructed Ancestral Chymase
Chandrasekharan, U. M., Sanker, S., Glynias, M. J., Karnik, S. S., & Husain, A. (1996) · Science · doi:10.1126/science.271.5248.502 · Cited by 208
The role of spironolactone in the treatment of patients with refractory hypertension
Ouzan, J., Perault, C., Lincoff, A. M., Carre, E., & Mertes, M. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02342-1 · Cited by 202
Biollaz, J., Brunner, H. R., Gavras, I., Waeber, B., & Gavras, H. (1982) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198211000-00014 · Cited by 191
Schillaci, G., & Vaudo, G. (2001) · PubMed · Cited by 167
(1965) · American Heart Journal · doi:10.1016/0002-8703(65)90198-5 · Cited by 154
Bradykinin Stimulates Tissue Plasminogen Activator Release in Human Vasculature
Brown, N. J., Gainer, J. V., Stein, C., & Vaughan, D. E. (1999) · Hypertension · doi:10.1161/01.hyp.33.6.1431 · Cited by 152
Cardiac angiotensinogen and its local activation in the isolated perfused beating heart.
Lindpaintner, K., Jin, M. W., Niedermaier, N., Wilhelm, M. J., & Ganten, D. (1990) · Circulation Research · doi:10.1161/01.res.67.3.564 · Cited by 149
Cloning and characterization of a human angiotensin II type 1 receptor
Bergsma, D. J., Ellis, C. E., Kumar, C. S., Nuthulaganti, P., Kersten, H., Elshourbagy, N. A., Griffin, E., Stadel, J. M., & Aiyar, N. V. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80288-8 · Cited by 148
Björn Fokow Award Lecture The angiotensin type 2 receptor
Unger, T. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917121-00001 · Cited by 133
Cardiac aldosterone production and ventricular remodeling
Delcayre, C., Silvestre, J., Garnier, A., Oubénaı̈ssa, A., Cailmail, S., Tatara, E., Bernard Swynghedauw, A., & Robert, V. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00973.x · Cited by 123
Physiological and Pathophysiological Functions of the AT2Subtype Receptor of Angiotensin II
Henrion, D., Kubis, N., & Levy, B. I. (2001) · Hypertension · doi:10.1161/hy1101.096109 · Cited by 115
The chymase-angiotensin system in humans
Husain, A. (1993) · Journal of Hypertension · doi:10.1097/00004872-199311000-00001 · Cited by 104
The chymase-angiotensin system in humans.
Husain, A. (1993) · PubMed · Cited by 98
Weber, M. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06584-9 · Cited by 98
Huraux, C., Makita, T., Kurz, S. K., Yamaguchi, K., Szlam, F., Tarpey, M. M., Wilcox, J. N., Harrison, D. G., & Levy, J. H. (1999) · Circulation · doi:10.1161/01.cir.99.1.53 · Cited by 95
Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart
Dzau, V. J. (1993) · Steinkopff eBooks · doi:10.1007/978-3-642-72497-8_1 · Cited by 90
Oparil, S., Guthrie, R. M., Lewin, A. J., Marbury, T. C., Reilly, K., Triscari, J. M., & Witcher, J. A. (1998) · Clinical Therapeutics · doi:10.1016/s0149-2918(98)80051-9 · Cited by 90
Self-citationExtra-adrenal Mineralocorticoids and Cardiovascular Tissue
Slight, S. H., Joseph, J., Ganjam, V. K., & Weber, K. T. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.0963 · Cited by 87
Hypertension : a companion to Brenner and Rector's the kidney
Oparil, S., & Weber, M. A. (2000) · Cited by 86
Self-citationTransient upregulation of the AT2 receptor mRNA level after global ischemia in the rat brain
Makino, I., Shibata, K., Ohgami, Y., Fujiwara, M., & Furukawa, T. (1996) · Neuropeptides · doi:10.1016/s0143-4179(96)90043-8 · Cited by 83
Angiotensin II Receptor Blockade: An Innovative Approach to Cardiovascular Pharmacotherapy
Eberhardt, R. T., Kevak, R. M., Kang, P. M., & Frishman, W. H. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb01939.x · Cited by 78
Cesari, M., Rossi, G. P., & Pessina, A. C. (2002) · Journal of Hypertension · doi:10.1097/00004872-200205000-00002 · Cited by 75
Inhibitors of Renin as Potential Therapeutic Agents
Wood, J. M., Stanton, J. L., & Hofbauer, K. G. (1987) · Journal of enzyme inhibition · doi:10.3109/14756368709020115 · Cited by 68
Choosing the Right ACE Inhibitor
Leonetti, G., & Cuspidi, C. (1995) · Drugs · doi:10.2165/00003495-199549040-00003 · Cited by 66
Fernandez, L. A., Caride, V. J., Strömberg, C., Näveri, L., & Wicke, J. D. (1994) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199424060-00011 · Cited by 57
Calhoun, D. A., Zaman, M. A., & Nishizaka, M. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0011-8 · Cited by 57
Self-citationEffects of candesartan cilexetil in patients with severe systemic hypertension
Oparil, S., Levine, J. H., ZUSCHKE, C. A., Gradman, A. H., Ripley, E. B. D., Jones, D. W., Hardison, J., Cushing, D. J., Prasad, R., & Michelson, E. L. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00278-7 · Cited by 56
Self-citationContribution of circulating renin to local synthesis of angiotensin peptides in the heart
Prescott, G., Silversides, D. W., CHIU, S. M. L., & Reudelhuber, T. L. (2000) · Physiological Genomics · doi:10.1152/physiolgenomics.2000.4.1.67 · Cited by 52
Effects of bradykinin B2 receptor antagonism on the hypotensive effects of ACE inhibition
Bouaziz, H., Joulin, Y., Safar, M. E., & Bénétos, A. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17052.x · Cited by 40
Mineralocorticoid receptors and hypertension
Funder, J. W. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00021-q · Cited by 22
Microalbuminuria reduction with valsartan
Wheeldon, N. M. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)01323-1 · Cited by 18
Burgess, E. D. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02421-4 · Cited by 6
Cited by
Chemistry and Biology Of Multicomponent Reactions
Dömling, A., Wang, W., & Wang, K. (2012) · Chemical Reviews · doi:10.1021/cr100233r · Cited by 2,547
Targeting proteases: successes, failures and future prospects
Turk, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2092 · Cited by 1,363
Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure
Patel, V. B., Zhong, J.-C., Grant, M. B., & Oudit, G. Y. (2016) · Circulation Research · doi:10.1161/circresaha.116.307708 · Cited by 833
Singh, K. D., & Karnik, S. S. (2020) · GPCRs · doi:10.1016/b978-0-12-816228-6.00020-9 · Cited by 704
Gradman, A. H., Schmieder, R. E., Lins, R. L., Nussberger, J., Chiang, Y., & Bedigian, M. P. (2005) · Circulation · doi:10.1161/01.cir.0000156466.02908.ed · Cited by 521
Metadata
- Authors
- Zaman, M. A., Oparil, S., & Calhoun, D. A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2002-08
- Volume
- 1
- Issue
- 8
- Pages
- 621-636
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1480141326
- Cited by
- 439
- References
- 103
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.